Tackling hearing loss

February 27, 2013
Tackling hearing loss
Credit: MED-EL

Some 16 per cent of European adults suffer from hearing loss that is severe enough to adversely affect their daily life. Hearing loss impacts on one's ability to communicate - to hear, process sound, and respond - which can make life frustrating. Untreated hearing loss can discourage social interaction, leading to depression, anxiety and isolation from the rest of the world. Sufferers also tend to express greater dissatisfaction with friendships, family life, health and finances. Depression is common in older adults who have trouble hearing.

In the majority of cases, hearing loss is a consequence of ageing or exposure to , and can be categorised by which part of the is damaged. There are three basic types of hearing loss: conductive hearing loss, sensorineural hearing loss, and mixed hearing loss. Sensorineural hearing loss is associated with the of hair cells in the inner ear. This age-related hearing reduction is a natural process, but can be rapid depending on individuals. It usually starts around 35 to 40 years of age. When we reach our 80s, more than half of us suffer from significant hearing loss. Finally, hearing loss can also be inherited (depending on your ) or be the consequence of an illness, medication, or exposure to chemicals.

However, scientists now believe that hearing loss could be conquered in the coming decades. Rapid advances in the and technology of hearing have made it realistic to envision a cure within the foreseeable future. The project NeuEarn is a one of these new technological advances that has come to life in the last few months.

This FP7-funded three year project was launched in September 2012 and led by a Danish SME called NsGene A/S, which specialises in the development of clinically and EU-compliant therapy devices. The NeuEar project has gathered industrialist and academic partners from Denmark, Sweden, Germany, Austria, UK and the US. The project aims to successfully commercialise this new implant within the next coming year, as it represents clear potential for clinical application. Today, untreated hearing loss costs Europe 213 billion euros a year. This medical condition has created a large worldwide market for , which was worth $725 million in 2008 and is expected to grow to $1.59 billion in 2013.

As indicated, a large proportion of the population is affected by sensorineural hearing loss (SNHL). Sensorineural hearing loss typically occurs following damage and loss of hair cells, the sensory cells in the cochlea of the inner ear, which, in response to sound, convert the mechanical vibrations into nerve impulses in the primary auditory neurons. The only currently available therapeutic intervention for patients suffering from sensorineural is the use of a cochlear implant, a neural prosthesis designed to directly electrically stimulate the auditory neurons. With a cochlear implant, the damaged are bypassed, and the auditory nerve is stimulated directly. The cochlear implant does not result in "restored" or "cured" hearing. It does, however, allow for the perception of the sensation of sound.

Despite improvements in cochlear implant technology, the hearing experience with these devices remains far from normal, partly due to a limited interface with the auditory neurons and their progressive degeneration.

The project NeuEar is developing an implant prototype capable of restoring hearing function and supporting regeneration of the auditory neurons. The implant will rescue the primary auditory neurons from degeneration, and will promote the neuron-electrode interface by creating chronic secretion of neurotrophic factors that would be combined with a cochlear electrode array. In addition, the project will pave the way for a stand-alone neurotrophic implant as a potential regenerative therapy to the without the use of an electrode.

The implant will not only improve hearing, it will significantly improve the quality of life of people. For those who have been deaf from birth, it does not provide completely 'normal' hearing, but for speech and understanding, it provides an effective stepping stone to a better quality of life.

Explore further: Know the types of hearing loss to find the right treatment

More information: For more information, please visit: NeuEar - www.neuear.eu/index.html

Related Stories

Know the types of hearing loss to find the right treatment

May 13, 2011
The solution for hearing loss isn’t just to turn up the volume on the TV—and the treatments available largely depend on the type of hearing loss a patient is experiencing.

Sensory hair cells regenerated, hearing restored in mammal ear

January 9, 2013
Hearing loss is a significant public health problem affecting close to 50 million people in the United States alone. Sensorineural hearing loss is the most common form and is caused by the loss of sensory hair cells in the ...

Recommended for you

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Best of Last Year – The top Medical Xpress articles of 2016

December 23, 2016
(Medical Xpress)—It was a big year for research involving overall health issues, starting with a team led by researchers at the UNC School of Medicine and the National Institutes of Health who unearthed more evidence that ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.